Sort   by:  
 Page size 
UnknownRetrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients.
Not available
S-EPMC7161150 | biostudies-literature
UnknownClinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.
Not available
S-EPMC6094880 | biostudies-literature
UnknownMuscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.
Not available
S-EPMC5091622 | biostudies-literature
UnknownEfficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Not available
S-EPMC5947636 | biostudies-literature
UnknownTIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients.
Not available
S-EPMC11443014 | biostudies-literature
UnknownWhole-genome sequencing of a sporadic primary immunodeficiency cohort.
Not available
S-EPMC7334047 | biostudies-literature
UnknownIntensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Not available
S-EPMC6652154 | biostudies-literature
UnknownClopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Not available
S-EPMC6193486 | biostudies-literature
Sort   by:  
 Page size